Autek China Inc. is a high-tech enterprise specializing in eye health and myopia prevention and control technology and services. The company's core products include orthokeratology lenses, general contact lenses, contact lens care products, and other eye health products. Its main product line features the "Dream David" series of corneal reshaping lenses designed to correct vision and slow the progression of myopia. In addition to manufacturing, Autek China provides ophthalmic and optometry medical devices as well as a range of optometry services, including the operation of eye care hospitals. The company focuses on integrated, personalized optometry services catering to customers across all age groups primarily in the domestic Chinese market. Founded in 2000, Autek China is headquartered in Hefei, China.
Recent strategic developments include the company's acquisition of a 75% equity stake in Suqian Shangyue Qicheng Hospital Management Co., Ltd., reflecting its expansion into hospital management and eye care service networks. Autek has also initiated production and deliveries of contact lenses from Jiangsu Duozi Medical and continues the promotion of its DK185 orthokeratology lens with increasing market adoption. Despite some performance pressures noted in the first half of 2025, including a slight revenue decline and reduced net profit, the company is actively investing in expanding its service terminals and product innovation. It operates through its Ophthalmology Services and Products segments and maintains a strong presence in China with ambitions for broader service integration.
Autek's industry focus spans medical equipment, eye care and optometry services, and ophthalmic device manufacturing. It holds recognized trademarks such as the “Dream David” series and has received accolades including the Anhui Pharmaceutical Quality Management Award and the Hefei Science and Technology Giant honor. The company utilizes both direct retail sales and strategic partnerships within China, underpinning its solid market position in the eye health sector.
In summary, Autek China Inc. offers a comprehensive suite of eye health products and services focused on vision correction and myopia control. Recent acquisitions and product launches illustrate its strategic shift towards enhancing both product offerings and healthcare service operations within China’s ophthalmology market, maintaining its commitment to technological innovation and integrated optometry solutions.